Diffuse esophageal spasm overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}} ; {{AE}} {{MSI}}
{{CMG}} ; {{AE}} {{MSI}}
==Overview==
==Overview==
Diffuse or Distal esophageal spasm (DES) is an uncommon esophageal motility disorder causing chest pain and/or dysphagia. Esophagus was described by Vasalius in 1543. Diffuse esophageal spasm was first described by Osgood in 1889. Diffuse esophageal spasm can be classified as primary or secondary based on presence or absence of other disease associated with it. The exact pathogenesis of DES is not fully understood. Current high-resolution manometric studies suggests impairment of inhibitory neurons. These inhibitory neurons use nitric oxide (NO) as neurotransmitter. Diffuse esophageal spasm must be differentiated from other [[diseases]] that cause [[dysphagia]], [[chest pain]] and [[weight loss]] such as [[Angina|angina,]] [[reflux esophagitis]], [[esophageal carcinoma]], [[systemic sclerosis]], [[Esophageal spasm|nutcracker esophagus]], hypertensive LES, [[Esophageal web|esophageal web/stricture]], [[pseudoachalasia]], [[stroke]], [[esophageal candidiasis]] and [[Chagas disease]] etc. Common risk factors in the development of Diffuse Esophageal Spasm include: Age (60-80 years), obesity, mitral valve prolapse, presence of GERD, Hypertension, anxiety or depression, and drinks (eg. red wine, very hot or cold liquid or fluid). If left untreated, most patient are symptom free over the course of time. Very few case report of progression to achalasia and nut cracker esophagus. The diagnostic study of choice for DES is manometry. An x-ray of esophagus after barium swallow (esophagogram) is the next best test to support manometric diagnosis. The hallmark of DES is esophageal dysphagia and chest pain. The mainstay of treatment for DES is medical therapy with [[Calcium channel blocker|calcium channel blockers]], and/or [[Tricyclic antidepressant|tricyclic antidepressants]].  
Diffuse or Distal esophageal spasm (DES) is an uncommon esophageal motility disorder causing chest pain and/or dysphagia. Esophagus was described by Vasalius in 1543. Diffuse esophageal spasm was first described by Osgood in 1889. Diffuse esophageal spasm can be classified as primary or secondary based on presence or absence of other disease associated with it. The exact pathogenesis of DES is not fully understood. Current high-resolution manometric studies suggests impairment of inhibitory neurons. These inhibitory neurons use nitric oxide (NO) as neurotransmitter. Exact cause of diffuse esophageal spasm is unknown. However, may be caused by consequence of various diseases and secondary to conditions like compression of nerves within esophageal wall, inflammation of the esophagus stricture, GERD, psychological conditions like anxiety or depression. Diffuse esophageal spasm must be differentiated from other [[diseases]] that cause [[dysphagia]], [[chest pain]] and [[weight loss]] such as [[Angina|angina,]] [[reflux esophagitis]], [[esophageal carcinoma]], [[systemic sclerosis]], [[Esophageal spasm|nutcracker esophagus]], hypertensive LES, [[Esophageal web|esophageal web/stricture]], [[pseudoachalasia]], [[stroke]], [[esophageal candidiasis]] and [[Chagas disease]] etc. Common risk factors in the development of Diffuse Esophageal Spasm include: Age (60-80 years), obesity, mitral valve prolapse, presence of GERD, Hypertension, anxiety or depression, and drinks (eg. red wine, very hot or cold liquid or fluid). If left untreated, most patient are symptom free over the course of time. Very few case report of progression to achalasia and nut cracker esophagus. The diagnostic study of choice for DES is manometry. An x-ray of esophagus after barium swallow (esophagogram) is the next best test to support manometric diagnosis. The hallmark of DES is esophageal dysphagia and chest pain. The mainstay of treatment for DES is medical therapy with [[Calcium channel blocker|calcium channel blockers]], and/or [[Tricyclic antidepressant|tricyclic antidepressants]].  
==Historical Perspective==
==Historical Perspective==
Esophagus was described by Vasalius in 1543. Diffuse esophageal spasm was first described by Osgood in 1889.
Esophagus was described by Vasalius in 1543. Diffuse esophageal spasm was first described by Osgood in 1889.

Revision as of 20:52, 21 November 2017

Diffuse esophageal spasm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diffuse esophageal spasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Diffuse esophageal spasm overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse esophageal spasm overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse esophageal spasm overview

CDC on Diffuse esophageal spasm overview

Diffuse esophageal spasm overview in the news

Blogs on Diffuse esophageal spasm overview

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Diffuse esophageal spasm overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]

Overview

Diffuse or Distal esophageal spasm (DES) is an uncommon esophageal motility disorder causing chest pain and/or dysphagia. Esophagus was described by Vasalius in 1543. Diffuse esophageal spasm was first described by Osgood in 1889. Diffuse esophageal spasm can be classified as primary or secondary based on presence or absence of other disease associated with it. The exact pathogenesis of DES is not fully understood. Current high-resolution manometric studies suggests impairment of inhibitory neurons. These inhibitory neurons use nitric oxide (NO) as neurotransmitter. Exact cause of diffuse esophageal spasm is unknown. However, may be caused by consequence of various diseases and secondary to conditions like compression of nerves within esophageal wall, inflammation of the esophagus stricture, GERD, psychological conditions like anxiety or depression. Diffuse esophageal spasm must be differentiated from other diseases that cause dysphagia, chest pain and weight loss such as angina, reflux esophagitis, esophageal carcinoma, systemic sclerosis, nutcracker esophagus, hypertensive LES, esophageal web/stricture, pseudoachalasia, stroke, esophageal candidiasis and Chagas disease etc. Common risk factors in the development of Diffuse Esophageal Spasm include: Age (60-80 years), obesity, mitral valve prolapse, presence of GERD, Hypertension, anxiety or depression, and drinks (eg. red wine, very hot or cold liquid or fluid). If left untreated, most patient are symptom free over the course of time. Very few case report of progression to achalasia and nut cracker esophagus. The diagnostic study of choice for DES is manometry. An x-ray of esophagus after barium swallow (esophagogram) is the next best test to support manometric diagnosis. The hallmark of DES is esophageal dysphagia and chest pain. The mainstay of treatment for DES is medical therapy with calcium channel blockers, and/or tricyclic antidepressants.

Historical Perspective

Esophagus was described by Vasalius in 1543. Diffuse esophageal spasm was first described by Osgood in 1889.

Classification

Pathophysiology

Causes

Differentiating Diffuse esophageal spasm from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References


Template:WikiDoc Sources